TY  - JOUR

T1  - Updated Survival, Quality of Life (QOL), and Safety Data of Radium-223 Chloride (RA-223) in Patients with Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases from the Phase 3 Double-Blind, Randomized, Multinational Study (ALSYMPCA)

JO  - Annals of Oncology

PY  - 2012/09/01

AU  - Parker C

AU  - Coleman RE

AU  - Nilsson S

AU  - Vogelzang N

AU  - Lloyd AJ

AU  - Staudacher K

AU  - van Gool R

AU  - Sartor AO

ED  - 

DO  - DOI: 10.1016/s0923-7534(20)33503-1

PB  - Elsevier BV

VL  - 23

SP  - ix296

EP  - ix296

Y2  - 2025/10/10

ER  -